PortfoliosLab logo

Astria Therapeutics, Inc. (ATXS)

Equity · Currency in USD · Last updated Sep 17, 2022

Company Info

ISINUS04635X1028
CUSIP04635X102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$9.21
Year Range$2.46 - $9.94
EMA (50)$6.12
EMA (200)$5.80
Average Volume$192.83K
Market Capitalization$119.89M

ATXSShare Price Chart


Chart placeholderClick Calculate to get results

ATXSPerformance

The chart shows the growth of $10,000 invested in Astria Therapeutics, Inc. in Jun 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $127 for a total return of roughly -98.73%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%AprilMayJuneJulyAugustSeptember
51.19%
-13.18%
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)

ATXSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M32.09%-10.03%
6M39.92%-12.20%
YTD84.04%-18.73%
1Y6.44%-13.56%
5Y-37.20%9.16%
10Y-45.36%8.83%

ATXSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-7.05%34.73%-0.59%-9.24%-39.24%-18.92%36.67%109.51%15.48%
202193.93%-30.60%0.35%-22.15%-9.33%3.43%-22.75%1.94%-11.33%-19.91%-10.17%-15.25%
2020-10.32%-7.92%-14.96%36.63%9.52%3.54%-10.11%14.19%-6.21%-78.35%23.13%29.70%
201945.77%-24.33%64.32%-5.18%-8.66%17.64%-12.27%-12.85%-12.48%-6.11%11.64%4.42%
2018-0.00%15.44%5.23%-10.50%7.41%-44.89%-28.05%2.90%12.68%-19.63%-3.11%-29.86%
201711.91%-70.30%33.33%-10.63%-6.29%5.22%-14.18%13.22%54.74%-3.77%-13.24%-15.82%
2016-16.52%-36.56%20.00%-12.50%53.06%-45.19%4.59%28.94%23.45%-43.99%3.48%1.12%
2015-6.08%6.47%-12.38%-28.97%-13.72%18.91%-4.46%

ATXSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Astria Therapeutics, Inc. Sharpe ratio is -0.00. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.00
-0.62
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)

ATXSDividend History


Astria Therapeutics, Inc. doesn't pay dividends

ATXSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-98.86%
-19.25%
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)

ATXSWorst Drawdowns

The table below shows the maximum drawdowns of the Astria Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Astria Therapeutics, Inc. is 99.72%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.72%Jul 24, 20151738Jun 16, 2022
-13.1%Jun 29, 20151Jun 29, 20154Jul 6, 20155
-9.94%Jul 13, 20151Jul 13, 20158Jul 23, 20159
-7.99%Jul 7, 20153Jul 9, 20151Jul 10, 20154

ATXSVolatility Chart

Current Astria Therapeutics, Inc. volatility is 57.76%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%AprilMayJuneJulyAugustSeptember
57.76%
30.01%
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)